Africa: What Fight Against Tuberculosis Can Teach Us About Fighting COVID-19

[Thomson Reuters Foundation] As governments around the world struggle to contain spiraling infections and an ever-increasing death toll from COVID-19, it's worth reflecting on what lessons we can draw from the long and still unfinished fight against tuberculosis (TB) - the world's most deadly infectious disease that kills nearly 1.5 million per year.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news

Related Links:

Scientists prepare to examine sewage in attempt to try to find the source of a Covid-19 infection that killed Nathan TurnerPassengers on the ill-fated Ruby Princess cruise ship have been sent another warning from the New South Wales health department, warning that they could have been exposed to tuberculosis.The Ruby Princess voyage that arrived in Sydney on 19 March is responsible for about 10% of all coronavirus infections in Australia, and the bungled management of the outbreak has sparked two separate inquires.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Health Australia news Science Queensland Source Type: news
CONCLUSIONS: There is a need to improve respiratory infectious disease procedures in our study hospitals, especially in outpatient and emergency departments. PMID: 32459978 [PubMed - as supplied by publisher]
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research
Traveling man: the Goodwill Ambassador shares a joke with two residents of a leprosarium in Krantau, Uzbekistan during a visit in 2013.By External SourceMay 29 2020 (IPS-Partners)   Warm greetings from Sasakawa Health Foundation in Tokyo. The 100th Issue of the WHO Goodwill Ambassador’s Newsletter has been published. Read special interviews with the Goodwill Ambassador and the UN Special Rapporteur on leprosy, and check out the Timeline of all that has happened since the first issue. My Journey Continues I started this newsletter in April 2003 to share information about the fight against leprosy. This marks th...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Health Source Type: news
In this report, we aim to convey our experience of multi-task treatment approach with convalescent immune plasma and anti-cytokine drug combination in a COVID-19 patient with extremely challenging comorbidities including active myeloid malignancy, disseminated tuberculosis and kidney failure.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Tags: Case Report Source Type: research
With any new illness comes metaphor. It is humanity ’s attempt to incorporate the mystery of disease into our own stories. We like to personify illness, give it human characteristics as a way of visualizing it. We name its actions to help lessen its unpredictability. Tuberculosis consumed. Syphilis punished. AIDS invaded. Cancer grows. COVID-19 qua rantines separate […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions COVID-19 coronavirus Infectious Disease Source Type: blogs
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received accelera...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Authors: Yadav SR, Kumar R, Gupta N, Ish P, Chakrabarti S, Kumar A Abstract To the Editor Novel Coronavirus disease (COVID-19) was first notified in December 2019 from Wuhan, China. Now, it has spread rapidly and has been declared a pandemic affecting over 200 countries with widespread morbidity and mortality. It has been postulated that the most vulnerable population are the elderly, people living in crowded areas, children and immune-compromised individuals, such as people living with human immunodeficiency virus (HIV). The correlation of tuberculosis (TB), HIV and malnutrition are well documented and hence, peop...
Source: Monaldi Archives for Chest Disease - Category: Respiratory Medicine Tags: Monaldi Arch Chest Dis Source Type: research
If the public is no longer reassured by the government ’s social distancing measures, I fear a second wave of coronavirusRichard Coker is emeritus professor of public health at the London School of Hygiene and Tropical MedicineSee all our coronavirus coverageCoronavirus – latest updatesThirty-five years ago, when I was working as a newly qualified doctor, I extracted a sausage from a woman ’s windpipe. She was, in the eyes of the ambulance crew who brought her in, probably beyond saving, possibly already dead. The woman had inhaled the sausage while laughing at a joke she’d been telling her family. ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Science UK news Dominic Cummings Politics Source Type: news
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, May 26 2020 (IPS) With well over five million Covid-19 infections worldwide, and deaths exceeding 340,000, the race for an effective vaccine has accelerated since the SARS-Cov-2 virus was first identified as the culprit. Expecting to score politically from being ‘first’ to have a vaccine, US President Trump’s Operation Warp Speed promises to get 300 million doses to Americans by January, after the November polls, following several failed attempts to monopolize vaccines being developed by European companies. Anis Chowdhury More than 115 vac...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news
[Daily Maverick] The Stop TB partnership predicts an additional 1.4 million people will die from TB by 2025 thanks to the Covid-19 response. In a webinar this week, international tuberculosis experts stressed the need for a united, integrated response to mitigate the effects of Covid-19.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
More News: African Health | COVID-19 | Infectious Diseases | Lessons | Teaching | Tuberculosis | Universities & Medical Training